GLMD   $3.79  9.54% Market Closed After Close 3.9 2.90%

Galmed Pharmaceuticals Ltd

EMA (20): 2024-10-01 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-10-02 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2024-10-04 the price crossed down the moving average line and trying to form a short-term downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type flat and down
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -34.73%
EMA (20) date of signal Oct. 1, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -25.72%
EMA (50) date of signal Oct. 2, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -11.37%
EMA (100) date of signal Oct. 4, 2024, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Oct. 18, 2024, 3 a.m.
MACD Signals bearish
MACD Yield -4.59%
MACD date of signal Oct. 15, 2024, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 8.09%
Stochastic date of signal Oct. 17, 2024, 3 a.m.
Updated Oct. 18, 2024, 11:02 p.m.